歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > PI3K/Akt/mTORsignaling > Zotarolimus

瀏覽歷史

S80550

Zotarolimus

源葉(MedMol) 98%
  • 英文名:
  • Zotarolimus
  • 別名:
  • 佐他莫司; 他莫司;;zotarolimus
  • CAS號(hào):
  • 221877-54-9
  • 分子式:
  • C52H79N5O12
  • 分子量:
  • 966.21
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車...
源葉(MedMol) S80550-1mg 98% ¥305.00元 10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80550-5mg 98% ¥884.00元 >10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80550-25mg 98% ¥2502.40元 6 - - - EA 加入購(gòu)物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: Zotarolimus, an analogue of rapamycin, inhibits FKBP-12 (IC50= 2.8 nM).
  • 靶點(diǎn): mTOR
  • 體內(nèi)研究:
    Zotarolimus potently inhibits adjuvant DTH(ED50=1.72 mg/kg/day), EAE(ED50=1.17 mg/kg/day), and cardiac allograft rejection(ED50=3.71 mg/kg/day)
  • 細(xì)胞實(shí)驗(yàn): Cell proliferation is assayed by measuring tritiated thymidine incorporation in vitro. Human coronary artery cells (hCa) are seeded into tissue culture flasks for expansion and applied to 96-well plates at desired density in complete media (5000 hCaSMC; 10 000 hCaEC). After 2 days, complete media is replaced with incomplete media to synchronize cells and induce G0 state. Two days later, incomplete media are removed and replaced with complete media (serum/growth factors) to induce G0 to G1 transition. Complete media also contain drug at desired concentrations to determine its effects on cell proliferation. On day 7, 3H-thymidine is added to cells to monitor DNA synthesis, and cells are harvested after overnight incorporation of radioactivity. After an incubation period of 72 h, 25 μL (1 μCi/well) of 3H-thymidine are added to each well. The cells are incubated at 37°C for 16-18 h to allow for incorporation of 3H-thymidine into newly synthesized DNA and the cells harvested onto 96-well plates containing bonded g
  • 動(dòng)物實(shí)驗(yàn): Male Sprague-Dawley rats was administrate by intravenous or oral Zotarolimus(2.5 mg/kg)dissolved inethanol: propylene glycol: cremophor EL: D5W vehicle (20: 30: 2: 48, by volume).
  • 參考文獻(xiàn):
    1.Chen YW, et al. J Cardiovasc Pharmacol, 2007, 49(4), 228-235. 2.Garcia-Touchard A, et al. Eur Heart J, 2006, 27(8), 988-1993.
  • 溶解性: Ethanol:93  mg/mL  (96.3  mM)    H2O:<1  mg/mL    DMSO:93  mg/mL  (96.3  mM)
  • 保存條件: 2-8℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.035 ml 5.175 ml 10.35 ml
    5 mM 0.207 ml 1.035 ml 2.07 ml
    10 mM 0.103 ml 0.517 ml 1.035 ml
    50 mM 0.021 ml 0.103 ml 0.207 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。